Therefore, the negative regulation of the focal adhesion signaling pathway through low ITGA10 expression can adversely affect the osteogenic function of alveolar BMSCs in T2DM patients and thus disturb implant osseointegration during the healing phase. The gene discussed is ITGA10; the disease is type 2 diabetes mellitus.